Clincosm LogoSign in Get a demo

acute myeloid leukemia

Showing 76 - 100 of 1,099
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Los Angeles, San Francisco (Azacitidine, Tagraxofusp-erzs)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +1 more
Jan 31, 2023

Acute Myeloid Leukemia Trial in Baltimore (Dose Escalation -tagraxofusp-erzs, Dose Expansion at RP2D -tagraxofusp-erzs)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Dose Escalation -tagraxofusp-erzs
  • Dose Expansion at RP2D -tagraxofusp-erzs
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 27, 2023

Acute Myeloid Leukemia Trial in Worldwide (Quizartinib, Intrathecal (IT) triple chemo prophylaxis, Fludarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Loma Linda, California
  • +36 more
Feb 1, 2023

Acute Myeloid Leukemia, Relapsed Cancer, Refractory Cancer Trial in Edmonton, Toronto (Enasidenib, Venetoclax)

Active, not recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Edmonton, Alberta, Canada
  • +1 more
Jan 31, 2023

Multiple Myeloma, MDS, Diffuse Large B Cell Lymphoma Trial in Denmark (Advance consultation concerning your life and treatment

Recruiting
  • Multiple Myeloma
  • +3 more
  • Advance consultation concerning your life and treatment (ACT )
  • Aalborg, Denmark
  • +6 more
Jan 31, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)

Recruiting
  • Acute Myeloid Leukemia
  • Graft cell infusion
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 29, 2023

Acute Myeloid Leukemia Trial in Beijing, Tianjin (LCAR-AMDR Cells Product)

Recruiting
  • Acute Myeloid Leukemia
  • LCAR-AMDR Cells Product
  • Beijing, Beijing, China
  • +1 more
Jan 28, 2023

Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia

Active, not recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Birmingham, Alabama
  • +190 more
Jan 30, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts-2 Trial in United States (drug,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Anchorage, Alaska
  • +506 more
Jan 28, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Boston (BXCL701)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-2
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 26, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Los Angeles, California
  • +5 more
Jan 27, 2023

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Worldwide (JNJ-74856665, AZA, VEN)

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Birmingham, Alabama
  • +22 more
Jan 27, 2023

Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Biospecimen Collection
  • +5 more
  • Buffalo, New York
  • +1 more
Jan 27, 2023

Acute Leukemias, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (JNJ-75276617)

Recruiting
  • Acute Leukemias
  • +2 more
  • Duarte, California
  • +28 more
Jan 27, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Biospecimen Collection
  • +2 more
  • Orange, California
  • +9 more
Jan 27, 2023

Disease State in Adult Acute Myeloid Leukemia Ineligible for

Recruiting
  • Acute Myeloid Leukemia
    • Athens, Attiki, Greece
    • +11 more
    Jan 26, 2023

    Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

    Recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • Recombinant Interleukin-7
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 26, 2023

    Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (Orca-T,

    Recruiting
    • Acute Myeloid Leukemia
    • +7 more
    • Orca-T
    • Standard-of-Care
    • Duarte, California
    • +13 more
    Jan 25, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +36 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jan 23, 2023

    Acute Myeloid Leukemia, MDS Trial in United States (SL-172154)

    Recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Duarte, California
    • +12 more
    Jan 23, 2023

    Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia Trial in United States (TTI-622, Azacitidine, Venetoclax)

    Recruiting
    • Lymphoma
    • +3 more
    • Los Angeles, California
    • +36 more
    Jan 23, 2023

    Acute Myeloid Leukemia Trial in United States (Standard Leukemia Care, Palliative Care)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Standard Leukemia Care
    • Palliative Care
    • Boston, Massachusetts
    • +3 more
    Jan 24, 2023

    Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial (Siremadlin)

    Recruiting
    • Acute Myeloid Leukemia
    • Allogeneic Stem Cell Transplantation
    • Tel Aviv, Israel
    • +2 more
    Jan 23, 2023

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Birmingham, Alabama
    • +8 more
    Jan 24, 2023